Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease (FOGG-I)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Lille
ClinicalTrials.gov Identifier:
NCT01108029
First received: July 20, 2009
Last updated: March 23, 2012
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2010
  Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
No publications provided by University Hospital, Lille

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):